According to a new study in the March 16 issue of the Journal of the Nationwide Cancer Institute.

In conclusion, HAART treatment might prevent surplus threat of [Kaposi sarcoma] and non-Hodgkin lymphoma, however, not that of Hodgkin lymphoma or various other cancers, the authors compose. Focusing on ways to encourage people contaminated with HIV to give up smoking would be effective in reducing lung cancer in these persons. .. Antiretroviral therapy may prevent excess threat of some cancers in people who have HIV In people contaminated with individual immunodeficiency virus , highly active anti-retroviral therapy may prevent most surplus cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the Nationwide Cancer Institute.It had been such a natural progression that, although no-one had looked at aromatase inhibitors in lung tumor before, it was a matter of period before someone did just, said Weinberg, who hopes the publication shall start her planned career as a pathologist. I always wanted to work with cancer, and I also wanted to learn about pathology. The HHMI fellowship i want to perform both for a 12 months. HHMI awards medical student research fellowships to enable medical learners to spend a year during their medical teaching doing research.